New research shows that giving aspirin to cancer patients along with immunotherapy could dramatically boost the effectiveness of the treatment.
Since its market release more than a century ago, aspirin has become one of the most widely used medications to treat pain, fever, and inflammation. Numerous studies have indicated that taking it daily reduces the risk of heart attack or stroke. In addition, some studies have concluded that taking aspirin on a regular basis may lower cancer risk. Recently, new research has suggested that aspirin could potentially increase the power of cancer immunotherapy treatments. How are the two linked?